Zeibdawi Abed R, Grundy Jean E, Lasia Bogna, Pryzdial Edward L G
Research and Development Department, Canadian Blood Services, 1800 Alta Vista Drive, Ottawa, Ontario, Canada K1G 4J5.
Biochem J. 2004 Jan 1;377(Pt 1):141-8. doi: 10.1042/BJ20031205.
Coagulation FVa (factor Va) accelerates the essential generation of thrombin by FXa (factor Xa). Although the noncovalent Ca2+-dependent association between the FVa light and heavy subunits (FVaL and FVaH) is required for function, little is known about the specific residues involved. Previous fragmentation studies and homology modelling led us to investigate the contribution of Leu-94-Asp-112. Including prospective divalent cation-binding acidic amino acids, nine conserved residues were individually replaced with Ala in the recombinant B-domainless FVa precursor (DeltaFV). While mutation of Thr-104, Glu-108, Asp-112 or Tyr-100 resulted in only minor changes to FXa-mediated thrombin generation, the functions of E96A (81%), D111A (70%) and D102A (60%) mutants (where the single-letter amino acid code is used) were notably reduced. The mutants targeting neighbouring acidic residues, Asp-79 and Glu-119, had activity comparable with DeltaFV, supporting the specific involvement of select residues. Providing a basis for reduced activity, thrombin treatment of D111A resulted in spontaneous dissociation of subunits. Since FVaH and FVaL derived from E96A or D102A remained associated in the presence of Ca2+, like the wild type, but conversely dissociated rapidly upon chelation, a subtle difference in divalent cation co-ordination is implied. Subunit interactions for all other single-point mutants resembled the wild type. These data, along with corroborating multipoint mutants, reveal Asp-111 as essential for FVa subunit association. Although Glu-96 and Asp-102 can be mutated without gross changes to divalent cation-dependent FVaH-FVaL interactions, they too are required for optimal function. Thus Glu-96-Asp-111 imparts at least two discernible effects on FVa coagulation activity.
凝血因子 FVa(因子 Va)可加速 FXa(因子 Xa)对凝血酶的关键生成作用。尽管 FVa 轻链和重链亚基(FVaL 和 FVaH)之间非共价的 Ca2+ 依赖性结合是其功能所必需的,但对于其中涉及的特定残基却知之甚少。先前的片段化研究和同源建模促使我们研究 Leu-94 - Asp-112 的作用。包括预期的二价阳离子结合酸性氨基酸在内,九个保守残基在重组无 B 结构域 FVa 前体(DeltaFV)中被逐个替换为丙氨酸。虽然 Thr-104、Glu-108、Asp-112 或 Tyr-100 的突变仅导致 FXa 介导的凝血酶生成有微小变化,但 E96A(81%)、D111A(70%)和 D102A(60%)突变体(使用单字母氨基酸代码)的功能显著降低。靶向相邻酸性残基 Asp-79 和 Glu-119 的突变体具有与 DeltaFV 相当的活性,这支持了特定残基的特定参与。为活性降低提供了依据,用凝血酶处理 D111A 导致亚基自发解离。由于源自 E96A 或 D102A 的 FVaH 和 FVaL 在 Ca2+ 存在下仍像野生型一样保持结合,但相反在螯合后迅速解离,这暗示了二价阳离子配位存在细微差异。所有其他单点突变体的亚基相互作用类似于野生型。这些数据以及多点突变体的佐证表明,Asp-111 对 FVa 亚基结合至关重要。虽然 Glu-96 和 Asp-102 可以在不显著改变二价阳离子依赖性 FVaH - FVaL 相互作用的情况下发生突变,但它们对于最佳功能也是必需的。因此,Glu-96 - Asp-111 对 FVa 凝血活性至少有两种可辨别的影响。